Frank Pasqualone

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Frank Pasqualone
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Pasqualone:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. SVP, CHIEF BUSINESS OFFICER Ordinary Shares 429,783 $4,422,467 $10.29 19 Nov 2021 Direct
Enveric Biosciences, Inc. Director Common Stock 7,904 $4,821 $0.6100 23 Dec 2025 Direct

Insider Reports Filed by Frank Pasqualone

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENVB Enveric Biosciences, Inc. 23 Dec 2025 1 $0 4 Director 30 Dec 2025, 16:40
ENVB Enveric Biosciences, Inc. 09 Oct 2024 1 $0 4 Director 11 Oct 2024, 19:14
ENVB Enveric Biosciences, Inc. 15 Sep 2023 1 +$2,140 4 Director 19 Sep 2023, 18:34
ENVB Enveric Biosciences, Inc. 13 Jul 2022 0 $0 3 Director 22 Jul 2022, 16:05
TBPH Theravance Biopharma, Inc. 19 Nov 2021 1 -$31,592 4 SVP, CHIEF BUSINESS OFFICER 23 Nov 2021, 19:25
TBPH Theravance Biopharma, Inc. 20 Aug 2021 1 -$53,095 4 SVP, Chief Business Officer 24 Aug 2021, 18:57
TBPH Theravance Biopharma, Inc. 20 May 2021 1 -$67,266 4 SVP, Chief Business Officer 24 May 2021, 18:12